FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160330004> ?p ?o ?g. }

• W3160330004 endingPage "4003" @default.
• W3160330004 startingPage "3989" @default.
• W3160330004 abstract "The tumor microenvironment is deeply involved in the process of tumor growth and development. In this study, we focused on cancer-associated fibroblasts (CAFs) and their derived exosomes on the lymphoma microenvironment to uncover their clinical significance. CAFs were established from primary lymphoma samples, and exosomes secreted from CAFs were obtained by standard procedures. We then investigated the roles of CAFs and their derived exosomes in the survival and drug resistance of lymphoma cells. CAFs supported the survival of lymphoma cells through increased glycolysis, and the extent differed among CAFs. Exosomes were identified as a major component of the extracellular vesicles from CAFs, and they also supported the survival of lymphoma cells. The suppression of RAB27B, which is involved in the secretion of exosomes, using a specific siRNA resulted in reduced exosome secretion and decreased survival of lymphoma cells. Moreover, anti-pyrimidine drug resistance was induced in the presence of exosomes through the suppression of the pyrimidine transporter, equilibrative nucleoside transporter 2 (ENT2), and the suppression of ENT2 was significant in in vivo experiments and clinical samples. RNA sequencing analysis of miRNAs in exosomes identified miR-4717-5p as one of the most abundant miRNAs in the exosome, which suppressed the expression of ENT2 and induced anti-pyrimidine drug resistance in vitro. Our results suggest that exosomes including miR-4717-5p secreted from CAFs play a pivotal role in the lymphoma microenvironment, indicating that they are a promising therapeutic target." @default.
• W3160330004 created "2021-05-24" @default.
• W3160330004 creator A5002642944 @default.
• W3160330004 creator A5017885084 @default.
• W3160330004 creator A5022946411 @default.
• W3160330004 creator A5023388437 @default.
• W3160330004 creator A5037946942 @default.
• W3160330004 creator A5040001548 @default.
• W3160330004 creator A5042332379 @default.
• W3160330004 creator A5055851471 @default.
• W3160330004 creator A5058578824 @default.
• W3160330004 creator A5068557516 @default.
• W3160330004 creator A5077833764 @default.
• W3160330004 creator A5081941961 @default.
• W3160330004 creator A5085722772 @default.
• W3160330004 date "2021-05-16" @default.
• W3160330004 modified "2023-10-16" @default.
• W3160330004 title "Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma" @default.
• W3160330004 cites W1173391493 @default.
• W3160330004 cites W1979751563 @default.
• W3160330004 cites W1981881499 @default.
• W3160330004 cites W1992048949 @default.
• W3160330004 cites W2018071905 @default.
• W3160330004 cites W2019728434 @default.
• W3160330004 cites W2024745748 @default.
• W3160330004 cites W2030701238 @default.
• W3160330004 cites W2035098923 @default.
• W3160330004 cites W2042508905 @default.
• W3160330004 cites W2051218702 @default.
• W3160330004 cites W2060133690 @default.
• W3160330004 cites W2068410289 @default.
• W3160330004 cites W2069774245 @default.
• W3160330004 cites W2101037339 @default.
• W3160330004 cites W2132598458 @default.
• W3160330004 cites W2133201432 @default.
• W3160330004 cites W2135608944 @default.
• W3160330004 cites W2142755954 @default.
• W3160330004 cites W2154624926 @default.
• W3160330004 cites W2166075265 @default.
• W3160330004 cites W2168044494 @default.
• W3160330004 cites W2169491358 @default.
• W3160330004 cites W2311676973 @default.
• W3160330004 cites W2433751364 @default.
• W3160330004 cites W2466470346 @default.
• W3160330004 cites W2473498748 @default.
• W3160330004 cites W2563723550 @default.
• W3160330004 cites W2744261860 @default.
• W3160330004 cites W2773804840 @default.
• W3160330004 cites W2901386374 @default.
• W3160330004 cites W2903308035 @default.
• W3160330004 doi "https://doi.org/10.1038/s41388-021-01829-y" @default.
• W3160330004 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8195743" @default.
• W3160330004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33994542" @default.
• W3160330004 hasPublicationYear "2021" @default.
• W3160330004 type Work @default.
• W3160330004 sameAs 3160330004 @default.
• W3160330004 citedByCount "19" @default.
• W3160330004 countsByYear W31603300042021 @default.
• W3160330004 countsByYear W31603300042022 @default.
• W3160330004 countsByYear W31603300042023 @default.
• W3160330004 crossrefType "journal-article" @default.
• W3160330004 hasAuthorship W3160330004A5002642944 @default.
• W3160330004 hasAuthorship W3160330004A5017885084 @default.
• W3160330004 hasAuthorship W3160330004A5022946411 @default.
• W3160330004 hasAuthorship W3160330004A5023388437 @default.
• W3160330004 hasAuthorship W3160330004A5037946942 @default.
• W3160330004 hasAuthorship W3160330004A5040001548 @default.
• W3160330004 hasAuthorship W3160330004A5042332379 @default.
• W3160330004 hasAuthorship W3160330004A5055851471 @default.
• W3160330004 hasAuthorship W3160330004A5058578824 @default.
• W3160330004 hasAuthorship W3160330004A5068557516 @default.
• W3160330004 hasAuthorship W3160330004A5077833764 @default.
• W3160330004 hasAuthorship W3160330004A5081941961 @default.
• W3160330004 hasAuthorship W3160330004A5085722772 @default.
• W3160330004 hasBestOaLocation W31603300041 @default.
• W3160330004 hasConcept C104317684 @default.
• W3160330004 hasConcept C145059251 @default.
• W3160330004 hasConcept C203014093 @default.
• W3160330004 hasConcept C20518536 @default.
• W3160330004 hasConcept C2776107976 @default.
• W3160330004 hasConcept C2779338263 @default.
• W3160330004 hasConcept C2781261824 @default.
• W3160330004 hasConcept C3020616263 @default.
• W3160330004 hasConcept C502942594 @default.
• W3160330004 hasConcept C55493867 @default.
• W3160330004 hasConcept C86803240 @default.
• W3160330004 hasConceptScore W3160330004C104317684 @default.
• W3160330004 hasConceptScore W3160330004C145059251 @default.
• W3160330004 hasConceptScore W3160330004C203014093 @default.
• W3160330004 hasConceptScore W3160330004C20518536 @default.
• W3160330004 hasConceptScore W3160330004C2776107976 @default.
• W3160330004 hasConceptScore W3160330004C2779338263 @default.
• W3160330004 hasConceptScore W3160330004C2781261824 @default.
• W3160330004 hasConceptScore W3160330004C3020616263 @default.
• W3160330004 hasConceptScore W3160330004C502942594 @default.
• W3160330004 hasConceptScore W3160330004C55493867 @default.
• W3160330004 hasConceptScore W3160330004C86803240 @default.
• W3160330004 hasFunder F4320309807 @default.

• next